DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Motzer RJ, Tannir NM, McDermott DF. et al.
Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma.
N Eng J Med 2018;
378: 1277-1290
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.